MSC2364447C

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSC2364447C, covering 2017-10-09 to 2017-10-09. Get the full timeline:

Most recent: Clinical Trial Update: MSC2364447C Phase 1b in Systemic Lupus Erythematosus [Phase 1]